Pharmafile Logo

Learning Program Webinar Series & Community Board

A Customer Story

Leveraging a combination of Impetus Digital’s best-in-class synchronous (real-time) virtual tools and our new asynchronous (over-time, anytime) Community Board and Resource Center offerings, we worked closely with our client–a Medical Education team from a large pharmaceutical company based in Europe–to produce a 4-part Learning Program for dermatologists, rheumatologists, and primary care providers (PCPs) on updates in scleroderma management.

The client’s main objectives were to:

  1. Create and disseminate an online pre-meeting questionnaire to all participants.
  2. Deliver monthly live webinars with expert speakers, including case study presentations, panel discussions, moderated breakout sessions, and Q&A sessions.
  3. Provide a fully 3D immersive experience to replicate the in-person meeting atmosphere as much as possible.
  4. Share chapterized recordings of the webinars in an on-demand Resource Center, along with other background readings and bite-sized video/audio clips.
  5. Provide a secure and interactive online space for ongoing best practice-sharing among the multidisciplinary participants.
  6. Empower participants to 1) accurately diagnose and effectively co-manage patients with scleroderma and 2) actively involve patients in their own care, as well as in clinical trials and other initiatives.

To learn more about our client’s approach and the outcomes of this project, access the full customer story at https://www.impetusdigital.com/2022/06/09/learning-program-webinar-series-community-board-a-customer-story/

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Virtual Steering Committee & Peer Influence Program

In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program.

How to Increase Engagement During Virtual Events

Tip #8 - Do you make sure to have a host for all your virtual events? Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Repurposing Off-Patent Drugs Through Crowd Funding

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

It is no secret that Pharma (still) has a major diversity problem.

How to Increase Engagement During Virtual Events

Tip #7 - How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

How to Increase Engagement During Virtual Events

Tip #6 - Individualizing a virtual event for your participants makes it more likely for them to attend and gain something valuable from the event. Learn how else you can...

How to Increase Engagement During Virtual Events

Tip #5 - Do you want to increase engagement during virtual events? To allow deep-dives into new data, discuss gaps/needs, or brainstorm new ideas, moderated small-group breakout sessions and workshops...

How to Increase Engagement During Virtual Events

Tip #4 - How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top...

How to Increase Engagement During Virtual Events

Tip #3 - Keep it simple! Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings

After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s what most KOLs want. It may...